| Molecular formula | C47H58N12O6 |
|---|
| Molecular weight | 887 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 6918297 |
|---|
Regulatory status
Hexarelin is classified as an unapproved research compound. It has no FDA-approved label, no approved brand name, and no established indication for human use.
What hexarelin is
Hexarelin is a synthetic peptide with the molecular formula C47H58N12O6 and a molecular weight of approximately 887. Its structure is catalogued under PubChem CID 6918297. No FDA label, mechanism of action statement, or approved pharmacologic class is available for this compound.
Trial footprint
Public registry data associated with this compound currently show no registered clinical trials. There are no sample trial records to report at this time.
FAQ
No. Hexarelin is classified as an unapproved research compound with no FDA-approved label, indication, or brand name. It is not approved for any human medical use.
Hexarelin is a synthetic peptide with the molecular formula C47H58N12O6 and a molecular weight of about 887. Its structure is catalogued in PubChem under CID 6918297.
Based on available registry data, there are currently no registered clinical trials for hexarelin. No trial phase or outcome information is available.
There is no adverse event reporting data available for hexarelin at this time. Because it lacks an approved label, no official side effect profile exists.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-09-19